Pregravid gamma-glutamyl transferase linked to gestational diabetes risk
Pregravid gamma-glutamyl transferase linked to gestational diabetes risk
By Will Boggs MD
NEW YORK (Reuters Health) - Elevated levels of
gamma-glutamyl transferase (GGT) before pregnancy are associated
with an increased risk of developing gestational diabetes,
according to results from a case-control study.
"Physicians should be aware that elevated GGT levels may be
an early sign of insulin resistance, even in the absence of
other clinical indications," Sneha B. Sridhar from Kaiser
Permanente Northern California in Oakland told Reuters Health by
email.
"Monitoring GGT levels before pregnancy may help to identify
women who are at increased risk for developing gestational
diabetes and who may benefit from interventions starting early
in pregnancy or even prior to pregnancy, to help maintain stable
blood sugar levels," she said.
Researchers know from past studies that liver enzyme levels
may change in response to the increased insulin resistance
induced by pregnancy, but it is unclear whether pre-pregnancy
levels of liver enzymes are related to the risk of subsequent
gestational diabetes (GDM).
Sridhar and colleagues used data from 4098 women who
completed a Multiphasic Health Checkup and subsequently
delivered an infant to investigate the possible association
between pregravid levels of GGT, alanine aminotransferase (ALT),
and aspartate aminotransferase (AST) and the risk of developing
GDM.
Two hundred fifty-six women went on to develop confirmed
GDM, and the researchers compared them to 497 matched controls,
according to the May 2 Diabetes Care online report.
There was a clear trend of increasing risk of GDM with
increasing quartile of GGT level, but this association
disappeared after adjustment for insulin sensitivity, fasting
status, and rate of gestational weight gain.
The association between GGT level and GDM risk was strongest
for women in the highest tertile of insulin resistance before
pregnancy, the researchers note, but there were no associations
in the two lower tertiles of insulin resistance.
In further analyses, there was an increasing risk of GDM
with increasing tertile of GGT when stratified by pre-pregnancy
BMI, and the greatest risk of GDM was seen in the highest
tertile of GGT with a pre-pregnancy BMI below 25.
Neither ALT nor AST was associated with an increased risk of
GDM.
"It is possible that the association between GGT and
subsequent GDM may be partly due to GGT being a marker of
exposure to environmental pollutants that act as endocrine
disruptors," Sridhar said. "While we were initially surprised by
the lack of association between ALT and subsequent GDM, past
research has been inconclusive on the relationship between ALT
and type 2 diabetes."
"This study appears to be the first to find that high levels
of GGT, measured years before pregnancy, are associated with
increased risk of gestational diabetes," Sridhar concluded.
"While more research is needed to determine why this is the
case, liver function tests are relatively inexpensive and may
someday help to inform the identification of women to target for
interventions designed to prevent gestational diabetes."
SOURCE: http://bit.ly/1kJCT5a
Diabetes Care 2014.
|